Moreover, using neutralizing antibodies against CXCL7, we have successfully shown inhibition of both tumor growth and distant metastasis (Figs. 4, S4), revealing a potential therapeutic opportunity of using CXCL7 antibodies for treating metastatic breast cancer. The gene discussed is PPBP; the disease is neoplasm.